{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:58:00Z","timestamp":1791917880912,"version":"4.3.4"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Preclinical and phase 1\/2 studies with esmolol hydrochloride suggest its potential role in treatment of diabetic foot ulcers (DFUs).<\/jats:p><\/jats:sec>Objective<\/jats:title>To study the efficacy of topical esmolol for healing of uninfected DFUs.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A randomized, double-blind, multicenter, phase 3 clinical trial was conducted from December 26, 2018, to August 19, 2020, at 27 referral centers across India. Participants included adults with DFUs.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Participants were randomized after a run-in phase (1 week) to receive esmolol, 14%, gel with standard of care (SoC), SoC only, or vehicle with SoC (3:3:1 proportion) for 12 weeks (treatment phase) and followed up subsequently until week 24.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was the proportion of wound closure within the 12-week treatment phase in the esmolol with SoC and SoC only groups. Analysis was conducted using an intention-to-treat safety evaluable population, full analysis set or efficacy-evaluable population, and per-protocol population comparing the esmolol plus SoC and SoC only treatment groups.<\/jats:p><\/jats:sec>Results<\/jats:title>In the study, 176 participants (122 men [69.3%]; mean [SD] age, 56.4 [9.0] years; mean [SD] hemoglobin A1c<\/jats:sub> level, 8.6% [1.6%]) with DFUs classified as University of Texas Diabetic Wound Classification system grade IA and IC (mean [SD] ulcer area, 4.7 [2.9] cm2<\/jats:sup>) were randomized to the 3 groups. A total of 140 participants were analyzed for efficacy. The proportion of participants in the esmolol with SoC group who achieved target ulcer closure within 12 weeks was 41 of 68 (60.3%) compared with 30 of 72 (41.7%) participants in the SoC only group (odds ratio [OR], 2.13; 95% CI, 1.08-4.17; P<\/jats:italic>\u2009=\u2009.03). A total of 120 participants completed the end of study visit which were analyzed. Target ulcer closure by the end of the study (week 24) was achieved in 44 of 57 (77.2%) participants in the esmolol with SoC group and 35 of 63 (55.6%) participants in the SoC only group (OR, 2.71; 95% CI, 1.22-5.99; P<\/jats:italic>\u2009=\u2009.01). The median time for ulcer closure was 85 days for the esmolol with SoC group and was not estimable for SoC only group. Significant benefits of Esmolol with SoC were seen in patients with factors that impede the healing of DFU. Treatment-emergent adverse events were noted in 18.8% of the participants, but most (87.3%) of these events were not attributable to the study drug.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this multicenter, randomized, double-blind clinical trial, the addition of esmolol to SoC was shown to significantly improve the healing of DFUs. With these results, topical esmolol may be an appropriate addition to SoC for treating DFUs.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03998436<\/jats:ext-link>; Clinical Trial Registry, India CRI Number: CTRI\/2018\/11\/016295<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.11509","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:37:42Z","timestamp":1684165062000},"page":"e2311509","source":"Crossref","is-referenced-by-count":29,"title":["Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers"],"prefix":"10.1001","volume":"6","author":[{"given":"Ashu","family":"Rastogi","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir A.","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"NovaLead Pharma, Pvt Ltd, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Grant Medical Foundation, Ruby Hall Clinic, Department of Diabetology, Cardiac OPD Medical Foundation, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza","family":"Akhtar","sequence":"additional","affiliation":[{"name":"N.K.P Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Digdoh Hills, Nagpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Arsule","sequence":"additional","affiliation":[{"name":"Sujata Birla Hospital & Medical Research Center, Opposite Bytco College, Nashik, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Bhamre","sequence":"additional","affiliation":[{"name":"Dr Vasantrao Pawar Medical College, Hospital & Research Centre Vasantdada Nagar, Adgaon Nashik, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bhosle","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Department of Clinical Pharmacology & Therapeutics, Mahatma Gandhi Mission Medical College & Hospital, Aurangabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Desai","sequence":"additional","affiliation":[{"name":"M.S. Ramaiah Hospital, Department of Vascular and Endovascular Surgery, M.S. Ramaiah Nagar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"Deenanath Mangeshkar Hospital & Research Center, Wound Healing Center, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Giriraja","sequence":"additional","affiliation":[{"name":"Rajalakshmi Hospital, Department of Clinical Research, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagannath","family":"Jagannath","sequence":"additional","affiliation":[{"name":"Department of Surgery, Sri Siddhartha Medical College and Research Centre, Tumkur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema Yuvraj","family":"Kashiva","sequence":"additional","affiliation":[{"name":"Noble Hospital Private Limited Hadapsar, Maharashtra, India, Hadapsar, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kesavan","sequence":"additional","affiliation":[{"name":"Apollo Hospitals, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Khandelwal","sequence":"additional","affiliation":[{"name":"Maharaja Agrasen Hospital, Department of Endocrinology, West Punjab Bagh, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kolte","sequence":"additional","affiliation":[{"name":"Sahyadri Hospital, Department of Surgery, Erandawane, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Kongara","sequence":"additional","affiliation":[{"name":"Endolife Speciality Hospitals, Guntur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Darivemula","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Gandhi Hospital, Secunderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Madhusudan","sequence":"additional","affiliation":[{"name":"Sapthagiri Institute of Medical Sciences and Research Centre Department of General Medicine, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Asif Haji","family":"Pyare Saheb Qureshi","sequence":"additional","affiliation":[{"name":"Crescent Hospital & Heart Centre, Department of Diabetology, Nagpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu","family":"Ramu","sequence":"additional","affiliation":[{"name":"Madras Diabetic Research Centre, Department of Diabetology, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunvant","family":"Rathod","sequence":"additional","affiliation":[{"name":"B.J. Medical College and Civil Hospital, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadasiva Rao","family":"Yalamanchi","sequence":"additional","affiliation":[{"name":"Yalamanchi Hospital, Suryaraopet, Vijayawada, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhit","family":"Shakya","sequence":"additional","affiliation":[{"name":"Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathvi","family":"Shetty","sequence":"additional","affiliation":[{"name":"Father Muller College and Hospital, Mangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudagar","family":"Singh","sequence":"additional","affiliation":[{"name":"Sri Ramachandra Hospital, Department of General Medicine, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supreet K.","family":"Deshpande","sequence":"additional","affiliation":[{"name":"NovaLead Pharma, Pvt Ltd, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"M.V. Hospital for Diabetes, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika G.","family":"Unnikrishnan","sequence":"additional","affiliation":[{"name":"Chellaram Diabetes Institute, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"1","key":"zoi230362r2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12902-018-0270-2","article-title":"Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus.","volume":"18","author":"Vibha","year":"2018","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"zoi230362r3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis.","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"issue":"11","key":"zoi230362r4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/dme.v36.11","article-title":"Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18-year study.","volume":"36","author":"Paisey","year":"2019","journal-title":"Diabet Med"},{"issue":"1","key":"zoi230362r5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4239\/wjd.v6.i1.37","article-title":"Literature review on the management of diabetic foot ulcer.","volume":"6","author":"Yazdanpanah","year":"2015","journal-title":"World J Diabetes"},{"issue":"12","key":"zoi230362r6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00592-019-01376-9","article-title":"Mortality in Asian Indians with Charcot\u2019s neuroarthropathy: a nested cohort prospective study.","volume":"56","author":"Chaudhary","year":"2019","journal-title":"Acta Diabetol"},{"key":"zoi230362r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108113","article-title":"Long term outcomes after incident diabetic foot ulcer: multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: Epidemiology of Diabetic Foot Complications study.","volume":"162","author":"Rastogi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"zoi230362r8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13047-020-00383-2","article-title":"Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer.","volume":"13","author":"Armstrong","year":"2020","journal-title":"J Foot Ankle Res"},{"key":"zoi230362r9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/dmrr.v28.S1","article-title":"Cost of treating diabetic foot ulcers in five different countries.","volume":"28","author":"Cavanagh","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"zoi230362r10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/wrr.12205","article-title":"Clinical application of growth factors and cytokines in wound healing.","volume":"22","author":"Barrientos","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"10","key":"zoi230362r11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010318.pub3","article-title":"Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus.","volume":"10","author":"Liu","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi230362r12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/nyas.13569","article-title":"Update on management of diabetic foot ulcers.","volume":"1411","author":"Everett","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"zoi230362r13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/wrr.2015.23.issue-2","article-title":"Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: a multicenter, randomized trial.","volume":"23","author":"Grek","year":"2015","journal-title":"Wound Repair Regen"},{"issue":"24","key":"zoi230362r14","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence.","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"issue":"S1","key":"zoi230362r15","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1002\/jcph.1986.26.issue-S1","article-title":"Pharmacology and pharmacokinetics of esmolol.","volume":"26","author":"Reynolds","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"zoi230362r16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.926129","article-title":"Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts.","volume":"13","author":"Kulkarni","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"zoi230362r17","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2022.0093","article-title":"Novel topical esmolol hydrochloride (Galnobax) for diabetic foot wound: phase 1\/2, multicenter, randomized, double-blind, vehicle-controlled parallel-group study.","author":"Rastogi","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"20","key":"zoi230362r18","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"zoi230362r19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S1067-2516(96)80125-6","article-title":"Classification of diabetic foot wounds.","volume":"35","author":"Lavery","year":"1996","journal-title":"J Foot Ankle Surg"},{"issue":"7247","key":"zoi230362r21","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/bmj.320.7247.1468","article-title":"Statistics notes: the odds ratio.","volume":"320","author":"Bland","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"zoi230362r22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcjd.2016.06.007","article-title":"Outcomes following advanced wound care for diabetic foot ulcers: a Canadian study.","volume":"41","author":"Roth-Albin","year":"2017","journal-title":"Can J Diabetes"},{"issue":"1","key":"zoi230362r23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5958\/0974-360X.2020.00021.9","article-title":"Effect of bodyweight, malnutrition and lifestyle modification on health related quality of life in diabetic foot ulcer patients.","volume":"13","author":"Logeshwary","year":"2020","journal-title":"Res J Pharm Tech"},{"key":"zoi230362r24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/dmrr.2698","article-title":"IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes.","volume":"32","author":"Hinchliffe","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"zoi230362r25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/wrr.v29.3","article-title":"Is there an association between anemia and diabetic foot ulcers? a systematic review and meta-analysis.","volume":"29","author":"Yammine","year":"2021","journal-title":"Wound Repair Regen"},{"issue":"7","key":"zoi230362r26","doi-asserted-by":"publisher","first-page":"239S","DOI":"10.1097\/01.prs.0000222891.74489.33","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial.","volume":"117","author":"Sheehan","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"zoi230362r27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/wrr.2008.16.issue-1","article-title":"Early healing rates and wound area measurements are reliable predictors of later complete wound closure.","volume":"16","author":"Cardinal","year":"2008","journal-title":"Wound Repair Regen"},{"issue":"1","key":"zoi230362r28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jdiacomp.2008.02.001","article-title":"Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing\u2014analysis of a single-center cohort of 704 diabetic patients.","volume":"23","author":"Coerper","year":"2009","journal-title":"J Diabetes Complications"},{"issue":"4","key":"zoi230362r29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.18388\/abp.2012_2085","article-title":"Molecular factors involved in the development of diabetic foot syndrome.","volume":"59","author":"Bruhn-Olszewska","year":"2012","journal-title":"Acta Biochim Pol"},{"issue":"3","key":"zoi230362r30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.diabres.2011.08.004","article-title":"Relationship between oxidative stress and apoptotic markers in lymphocytes of diabetic patients with chronic non healing wound.","volume":"94","author":"Arya","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"zoi230362r31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WON.0b013e3181c68b61","article-title":"Wound nitric oxide bioactivity: a promising diagnostic indicator for diabetic foot ulcer management.","volume":"37","author":"Boykin","year":"2010","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"14","key":"zoi230362r32","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1096\/fsb2.v13.14","article-title":"Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair.","volume":"13","author":"Frank","year":"1999","journal-title":"FASEB J"},{"issue":"1","key":"zoi230362r33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-016-1419-x","article-title":"Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock.","volume":"20","author":"Hern\u00e1ndez","year":"2016","journal-title":"Crit Care"},{"issue":"9","key":"zoi230362r34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S2213-8587(16)30012-2","article-title":"Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality.","volume":"4","author":"Jeffcoate","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"zoi230362r1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 9th edition. International Diabetes Federation. 2019. Accessed October 1, 2021. http:\/\/www.diabetesatlas.org"},{"key":"zoi230362r20","unstructured":"Ganesh? V, Kakulte? K. WoundlyClinical: a digital wound documentation tool. December 1, 2019. Accessed March 24, 2023. https:\/\/zenodo.org\/record\/4066393#.ZB2-D3bMKUk"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2804872\/rastogi_2023_oi_230362_1683317800.77756.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:37:47Z","timestamp":1684165067000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2804872"}},"subtitle":["A Phase 3 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.11509","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]}}}